
Medicine and Health
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID-19
B. Boras, R. M. Jones, et al.
Discover how PF-07304814, a groundbreaking phosphor prodrug of the potent 3CL protease inhibitor PF-00835231, could revolutionize COVID-19 treatment. With impressive antiviral effects and promising synergy with remdesivir, this innovative research, conducted by a team including Britton Boras and Dan Arenson, paves the way for new therapeutic options against coronaviruses.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.